These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29654728)

  • 21. [Cytoimmunological profile of cerebrospinal fluid in diagnosis of multiple sclerosis].
    Caudie C; Birouk AM; Bancel J; Claudy D; Gignoux L; Vukusic S; Confavreux C
    Pathol Biol (Paris); 2005 Mar; 53(2):68-74. PubMed ID: 15708649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpretation of cerebrospinal fluid protein assays in various neurologic diseases.
    Christenson RH; Behlmer P; Howard JF; Winfield JB; Silverman LM
    Clin Chem; 1983 Jun; 29(6):1028-30. PubMed ID: 6851088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of isoelectric focusing of cerebrospinal fluid immunoglobulin G in the early biological assessment of multiple sclerosis].
    Caudie C; Allauzen O; Bancel J; Later R
    Ann Biol Clin (Paris); 2000; 58(2):187-93. PubMed ID: 10760705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of immunological variables in neuroborreliosis and multiple sclerosis.
    Bednárová J; Stourac P; Adam P
    Acta Neurol Scand; 2005 Aug; 112(2):97-102. PubMed ID: 16008535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic usefulness of cerebrospinal fluid in multiple sclerosis.
    Mehta PD
    Crit Rev Clin Lab Sci; 1991; 28(3):233-51. PubMed ID: 1905549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis.
    Gastaldi M; Zardini E; Franciotta D
    Expert Rev Mol Diagn; 2017 Jan; 17(1):31-46. PubMed ID: 27911122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset.
    Vasilj M; Kes VB; Vrkic N; Vukasovic I
    Clin Neurol Neurosurg; 2018 Nov; 174():220-229. PubMed ID: 30278299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis.
    Gamraoui S; Mathey G; Debouverie M; Malaplate C; Anxionnat R; Guillemin F; Epstein J
    J Neurol; 2019 Apr; 266(4):902-909. PubMed ID: 30707357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of virus-specific intrathecally synthesised immunoglobulin G with a fully automated enzyme immunoassay system.
    Schubert J; Weissbrich B
    BMC Neurol; 2007 May; 7():12. PubMed ID: 17535416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis.
    Livrea P; Simone IL; Trojano M; Pisicchio L; Logroscino G; Rosato A
    Riv Neurol; 1987; 57(3):189-96. PubMed ID: 3672011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gel isoelectric focusing and IgG index for demonstration of intrathecal IgG synthesis in neurological disorders.
    Van den Bergh FA; Roos RA
    Ann Clin Biochem; 1981 May; 18(Pt 3):153-7. PubMed ID: 7283365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of IgG and albumin in CSF and serum from multiple sclerosis patients by enzyme-linked immunosorbent assay.
    Mehta PD; Mehta SP
    Acta Neurol Scand; 1987 Feb; 75(2):125-9. PubMed ID: 3107335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relation between the clinical and cerebrospinal fluid parameters in multiple sclerosis, with special reference to subjects without oligoclonal IgG in the cerebrospinal fluid].
    Poloni M; Rocchelli B; Mazzarello P; Delodovici M
    Riv Neurol; 1981; 51(2):69-80. PubMed ID: 7244541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of oligoclonal immunoglobulin G bands in multiple sclerosis cerebrospinal fluid by immunoblotting and immunofixation.
    Mehta PD; Patrick BA; Black J
    Electrophoresis; 1988 Mar; 9(3):126-8. PubMed ID: 2466650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical usefulness of oligoclonal bands].
    Falip M; Tintoré M; Jardí R; Duran I; Link H; Montalbán X
    Rev Neurol; 2001 Jun 16-30; 32(12):1120-4. PubMed ID: 11562840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oligoclonal antibodies in the diagnosis of multiple sclerosis and other diseases of the nervous system].
    Losy J
    Neurol Neurochir Pol; 1991; 25(3):363-70. PubMed ID: 1961384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analytical performances of SPAPLUS® turbidimeter for the dosage of immunoglobulins and beta-2 microglobulin in serum].
    Thevenet I; Benat C; Chauzeix J; Blancher A; Puissant-Lubrano B
    Ann Biol Clin (Paris); 2014; 72(4):423-34. PubMed ID: 25119800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sclerosis: diagnostic usefulness of cerebrospinal fluid.
    Johnson KP; Nelson BJ
    Ann Neurol; 1977 Nov; 2(5):425-31. PubMed ID: 103485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRZH reaction increases sensitivity for intrathecal IgG synthesis in IgG Oligoclonal band negative Multiple Sclerosis patients.
    Dias-Carneiro RP; von Glehn F; Moraes AS; Boldrini VO; Damasceno A; Andrade MD; Lima AC; Casanova CS; Tilbery CP; Damasceno BP; Santos LM; Brandão CO
    J Neuroimmunol; 2016 Nov; 300():30-35. PubMed ID: 27806873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.
    Link H; Tibbling G
    Scand J Clin Lab Invest; 1977 Sep; 37(5):397-401. PubMed ID: 337461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.